Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Weydt

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
The Lancet. Neurology|October 18, 2024
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trialJan C Koch, Andreas Leha, Helen Bidner, et al.
Annals of Neurology|August 9, 2025
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral SclerosisChristina Steffke, Karthik Baskar, Franziska Bachhuber, et al.
Nature Neuroscience|March 25, 2015
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementiaAxel Freischmidt, Thomas Wieland, Benjamin Richter, et al.
Eclinicalmedicine|February 22, 2024
Effects of tofersen treatment in patients with <i>SOD1</i>-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access programMaximilian Wiesenfarth, Johannes Dorst, David Brenner, et al.
Neurological Research and Practice|July 3, 2024
Patients' and caregivers' perception of multidimensional and palliative care in amyotrophic lateral sclerosis - protocol of a German multicentre studyKatharina Linse, Constanze Weber, Peter Reilich, et al.
Brain : a Journal of Neurology|January 18, 2018
Hot-spot KIF5A mutations cause familial ALSDavid Brenner, Rüstem Yilmaz, Kathrin Müller, et al.
Nature Medicine|June 18, 2024
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALSMadhurima Chatterjee, Selcuk Özdemir, Christian Fritz, et al.
Nature Genetics|July 22, 2024
Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findingsAxel Schmidt, Magdalena Danyel, Kathrin Grundmann, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
The Lancet. Neurology|October 18, 2024
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trialJan C Koch, Andreas Leha, Helen Bidner, et al.
Annals of Neurology|August 9, 2025
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral SclerosisChristina Steffke, Karthik Baskar, Franziska Bachhuber, et al.
Nature Neuroscience|March 25, 2015
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementiaAxel Freischmidt, Thomas Wieland, Benjamin Richter, et al.
Eclinicalmedicine|February 22, 2024
Effects of tofersen treatment in patients with <i>SOD1</i>-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access programMaximilian Wiesenfarth, Johannes Dorst, David Brenner, et al.
Neurological Research and Practice|July 3, 2024
Patients' and caregivers' perception of multidimensional and palliative care in amyotrophic lateral sclerosis - protocol of a German multicentre studyKatharina Linse, Constanze Weber, Peter Reilich, et al.
Brain : a Journal of Neurology|January 18, 2018
Hot-spot KIF5A mutations cause familial ALSDavid Brenner, Rüstem Yilmaz, Kathrin Müller, et al.
Nature Medicine|June 18, 2024
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALSMadhurima Chatterjee, Selcuk Özdemir, Christian Fritz, et al.
Nature Genetics|July 22, 2024
Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findingsAxel Schmidt, Magdalena Danyel, Kathrin Grundmann, et al.
Pageof 11